Article
Division will focus on ophthalmic clinical trials
Princeton, NJ-Advanced Biomedical Research Inc. has launched a new ophthalmic division, called ABR InVision, devoted to conducting clinical studies in glaucoma, retinal and corneal diseases, cataract, refractive surgery, and neuroprotection.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
